Tuesday, May 27, 2014

Fwd: Google Alert - Cancer research



Sent from my iPad

Begin forwarded message:

From: Google Alerts <googlealerts-noreply@google.com>
Date: May 27, 2014 10:01:05 PM CDT
To: bobbygmartin1938@gmail.com
Subject: Google Alert - Cancer research

Google
Cancer research
Daily update May 28, 2014
NEWS
Ovarian Cancer Research Fund grant to start gynecologic cancer patient support program
Women recently diagnosed with gynecologic cancer at Baylor College of Medicine clinics will have access to a new support program that pairs ...
Google Plus Facebook Twitter Flag as irrelevant
Beverley Guardian
Yorkshire Cancer Research Spring Fever
We are indebted to Mortimers who have raised over £10,000 for Yorkshire Cancer Research through a "Buy A Brick Appeal" to their customers and ...
Google Plus Facebook Twitter Flag as irrelevant
Children's Hospital Los Angeles Wins Rally Foundation Grant For Childhood Cancer Research
Rally Foundation for Childhood Cancer Research (Rally), a national non-profit organization, has awarded a $40,000 Rally for Research Grant to ...
Google Plus Facebook Twitter Flag as irrelevant
ThisWeekNews
June 4 fundraiser supports bile-duct cancer research
The fundraiser will feature grilled sandwiches, pizza and beverages from Hills, with a portion of sales benefiting the cancer-research fund; music by ...
Google Plus Facebook Twitter Flag as irrelevant
Skokie School students go bald to support cancer research
Skokie School fifth graders Chris Hawk (left) and Will Frohling receive haircuts from Donna Cleland and Karolina Palka as they raise money for the St.
Google Plus Facebook Twitter Flag as irrelevant
St. Jude doctors on the cutting edge of cancer research, treatment
MEMPHIS, Tenn. – St. Jude has treated children from all over the world, all 50 states including Idaho, and each year, on average, St. Jude treats over ...
Google Plus Facebook Twitter Flag as irrelevant
Get documents shredded at cancer research fundraising event
Tbo.com (blog)
The shredding event hosted by ProShred called "Shred Cancer" will be accepting donations to benefit the American Institute for Cancer Research.
Google Plus Facebook Twitter Flag as irrelevant
FreshPlaza
Pink Lady® raises over £64000 for cancer research
Tesco and Pink Lady® have announced that they are donating over £64,500 to Cancer Research UK after sales of its co-branded Race for Life tray ...
Google Plus Facebook Twitter Flag as irrelevant
Lemonade Stand in Chaska Benefits Childhood Cancer Research
The Stepping Stones program at the SouthWest Metro Educational Cooperative is manning a lemonade stand for the third year in a row. Students are ...
Google Plus Facebook Twitter Flag as irrelevant
Theralase Anti-Cancer Technology Validated in Prestigious US Chemistry Publication
The results of our collaborative research with Dr. Lothar Lilge's scientific team at Princess Margaret Cancer Centre, University Health (UHN) and Dr.
Google Plus Facebook Twitter Flag as irrelevant
BLOGS
Tour de Campus supports cancer research
ANU Newsroom u5546890
ANU cyclists have thrown their support behind an epic charity ride for cancer research, joining cyclist Chris Gruar as he nears the end of a gruelling ...
Google Plus Facebook Twitter Flag as irrelevant
Edit this alert
You have received this email because you have subscribed to Google Alerts.
RSS Receive this alert as RSS feed
Send Feedback

Saturday, May 24, 2014

Fwd: Pain Killers Improve Metabolic Health and Longevity; CHMP Positive About Muscular Dystrophy Drug



Sent from my iPad

Begin forwarded message:

From: Kent Castle <kent.d.castle@hotmail.com>
Date: May 24, 2014 5:50:16 PM CDT
To: Reason Marilou <loganlou55@yahoo.com>, Bogan Carole <bcbogan@earthlink.net>, Patterson James <w8ljz@aol.com>, Astrology Valkyrie <astrogoddess@valkyrieastrology.com>, Madsen Ron <ronstar@pdq.net>, Martin Bobby <bobbygmartin1938@gmail.com>, Matthews-Schmidt Linda <linda.j.matthews-schmidt@nasa.gov>, Kelley Mary <mary.n.kelley@nasa.gov>, Stringer Suzan <suzan.f.stringer@nasa.gov>, Chamberlain Sharon <sharon.m.chamberlain@saic.com>, Williams Tom <gtomwill@att.net>, Heidel TQ <bheidel@highland.net>, Delwood James <jamesdelwood@clear.net>
Subject: FW: Pain Killers Improve Metabolic Health and Longevity; CHMP Positive About Muscular Dystrophy Drug


 

From: reply@mail.dddmag.com
To: KENT.D.CASTLE@HOTMAIL.COM
Subject: Pain Killers Improve Metabolic Health and Longevity; CHMP Positive About Muscular Dystrophy Drug
Date: Fri, 23 May 2014 13:01:33 -0600
Interesting pain and itch antibody found --------------------------------------
View this email in your browser.
Formulatrix
MAY
23
Drug Discovery & Development Update
IN THIS ISSUE
  NEWS  
  CHMP Positive About Muscular Dystrophy Drug  
  NEWS  
  FDA Clears Kick Off of Phase 3 Alzheimer's Disease Study  
  NEWS  
  Viking Signs Licensing Deal for Novel Therapeutic Programs  
  NEWS  
  One Molecule Blocks Both Pain and Itching  
  NEWS  
  Biologics Formulation Summit Highlights Best Practices  

Read Waters Beginner's Guide to SPE

The Beginner's Guide to SPE is a must read for anyone starting out in analytical chromatography or seasoned chemists looking to add solid-phase extraction to their skill set.

LEARN MORE
FEATURED STORY

Pain Killers Improve Metabolic Health and Longevity

Featured Story
Blocking a pain receptor in mice not only extends their lifespan, suggesting that pain might drive the aging process, it also gives them a more youthful metabolism, including an improved insulin response that allows them to deal better with high blood sugar. Read more...

Share Facebook Twitter Google+ LinkedIn StumbleUpon

FULL STORY

UPLC AND HPLC COLUMNS FOR GLYCAN ANALYSIS

Waters now offers both UPLC and HPLC, BEH-based columns for analyzing labeled, N-linked glycans from biotherapeutic proteins. Chromatographers can now choose the most appropriate LC-based technology to address their specific released glycan analysis application needs and laboratory instrumentation.

LEARN MORE
NEWS

CHMP Positive About Muscular Dystrophy Drug

Thumbnail
PTC Therapeutics Inc. announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion regarding the company's application for a conditional marketing authorization of Translarna (ataluren) for the treatment of Duchenne muscular dystrophy. Read more...

FULL STORY
NEWS

FDA Clears Kick Off of Phase 3 Alzheimer's Disease Study

Thumbnail
AZTherapies Inc., a company developing novel treatments for Alzheimer's disease based on technology licensed from Massachusetts General Hospital, announced that it has received notice from FDA that it may proceed with the Phase 3 clinical study submitted in its IND application. Read more...

FULL STORY

Maverick Isotyped Immunogenicity Assay

The Maverick MT-ADA assay simplifies immunogenicity testing by combining screening, confirmatory, and isotyping tiers into a single assay providing real-time detection of anti-drug antibodies.

MORE INFO
NEWS

Viking Signs Licensing Deal for Novel Therapeutic Programs

Thumbnail
Viking Therapeutics Inc., a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders, announced that it has obtained an exclusive worldwide license to five therapeutic programs from Ligand Pharmaceuticals. Read more...

FULL STORY
NEWS

One Molecule Blocks Both Pain and Itching

Thumbnail
Duke University researchers have found an antibody that simultaneously blocks the sensations of pain and itching by targeting the voltage-sensitive sodium channels in the cell membrane of neurons in studies with mice. Read more...     

FULL STORY
NEWS

Biologics Formulation Summit Highlights Best Practices

Thumbnail
Freeslate Inc., a provider of high throughput research solutions for biopharmaceutical development, announced highlights of its Biologics Formulation Summit held at Janssen Pharmaceutical in Malvern, Pennsylvania. Read more...       

FULL STORY
NEWS

Novartis to Show Key Advances in Cancer Research

Thumbnail
Novartis is showcasing the results of research efforts to target disease pathways at upcoming cancer-focused meetings, including updated data in ALK+ non-small cell lung cancer and the first-ever presentations of key data in polycythemia vera, multiple myeloma  and locally advanced or metastatic basal cell carcinoma. Read more...

FULL STORY
Drug Discovery & Development
Facebook Twitter
SUBSCRIBEUNSUBSCRIBEABOUT USADVERTISE
This email was sent by: Drug Discovery & Development
100 Enterprise Drive - Suite 600 - Rockaway, NJ 07866-2129
We respect your right to privacy - click here to view our policy.

©2014 Drug Discovery & Development. All rights reserved.